These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11797507)

  • 41. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.
    Beckers C; Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Kaiser MJ; Hustinx R; Foidart J; Malaise MG
    J Nucl Med; 2004 Jun; 45(6):956-64. PubMed ID: 15181130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anterior layering of excreted 18F-FDG in the bladder on PET/CT: frequency and cause.
    Purcell DD; Coakley FV; Franc BL; Hawkins RA; Boddington SE; Yeh BM
    AJR Am J Roentgenol; 2007 Aug; 189(2):W96-9. PubMed ID: 17646448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
    Lee HY; Chung JK; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC
    Ann Nucl Med; 2008 May; 22(4):281-6. PubMed ID: 18535878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
    Utriainen M; Metsähonkala L; Salmi TT; Utriainen T; Kalimo H; Pihko H; Mäkipernaa A; Harila-Saari A; Jyrkkiö S; Laine J; Någren K; Minn H
    Cancer; 2002 Sep; 95(6):1376-86. PubMed ID: 12216107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDG uptake, tumour characteristics and response to therapy: a review.
    Smith TA
    Nucl Med Commun; 1998 Feb; 19(2):97-105. PubMed ID: 9548192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. F-18 FDG PET in detecting uterine leiomyoma.
    Lin CY; Ding HJ; Chen YK; Liu CS; Lin CC; Kao CH
    Clin Imaging; 2008; 32(1):38-41. PubMed ID: 18164393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences of articular and extra-articular involvement in polymyalgia rheumatica: A comparison by whole-body FDG-PET/CT.
    Kaneko K; Suematsu E; Miyamura T; Ishioka H
    Mod Rheumatol; 2020 Mar; 30(2):358-364. PubMed ID: 30843747
    [No Abstract]   [Full Text] [Related]  

  • 49. Detection of the inflammatory process in a Behçet's disease-like mouse model using 18F-fluorodeoxyglucose positron emission tomography.
    Cho SB; Sohn S; Zheng Z; Cho A; Kim H; Kang WJ; Bang D; Yun M; Lee JD; Lee JH
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):47-53. PubMed ID: 23739526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Semi-quantitative measurements of normal organs with variable metabolic activity on FDG PET imaging.
    Tan LT; Ong KL
    Ann Acad Med Singap; 2004 Mar; 33(2):183-5. PubMed ID: 15098631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PET/computed tomography shows association between subjective pain in knee joints and fluorine-18-fluorodeoxyglucose uptake.
    Kamasaki T; Mori K; Taira Y; Orita M; Miyamoto I; Usui T; Chiba K; Kudo T; Takamura N
    Nucl Med Commun; 2020 Mar; 41(3):241-245. PubMed ID: 31842183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Visualization of normal organs in whole-body FDG-PET imaging].
    Kato T; Tsukamoto E; Suginami Y; Mabuchi M; Yoshinaga K; Takano A; Adachi I; Shiga T; Morita K; Katoh C; Kuge Y; Tamaki N
    Kaku Igaku; 1999 Dec; 36(9):971-7. PubMed ID: 10659581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. F-18 FDG uptake in the large arteries: a new observation.
    Yun M; Yeh D; Araujo LI; Jang S; Newberg A; Alavi A
    Clin Nucl Med; 2001 Apr; 26(4):314-9. PubMed ID: 11290891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Normal cerebral FDG uptake during childhood.
    London K; Howman-Giles R
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):723-35. PubMed ID: 24323306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Technical bases and regulatory principles].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S18-22. PubMed ID: 12739333
    [No Abstract]   [Full Text] [Related]  

  • 56. Benign causes of 18-FDG uptake on whole body imaging.
    Bakheet SM; Powe J
    Semin Nucl Med; 1998 Oct; 28(4):352-8. PubMed ID: 9800240
    [No Abstract]   [Full Text] [Related]  

  • 57. [Using isotopes with short half-life in the diagnostics of oncological diseases].
    Minn H; Kööbi T; Ahonen A
    Duodecim; 2003; 119(1):26-32. PubMed ID: 12607469
    [No Abstract]   [Full Text] [Related]  

  • 58. Basic data on anthropometric measurements and angular measurements of the hip and knee joints for selected age groups 1-74 years of age.
    Johnson CL; Fulwood R; Abraham S; Bryner JD
    Vital Health Stat 11; 1981 Apr; (219):1-68. PubMed ID: 15806754
    [No Abstract]   [Full Text] [Related]  

  • 59. A rare form of malignant joint tumor.
    SONNENSCHEIN A
    J Bone Joint Surg Am; 1951 Jul; 33-A(3):719-22. PubMed ID: 14850512
    [No Abstract]   [Full Text] [Related]  

  • 60. [Symptoms and pathology of synovialomata of the joints].
    HAGE W
    Zentralbl Chir; 1952; 77(9):376-8. PubMed ID: 14951859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.